Carvacrol is a monoterpenic phenol and an active ingredient of the plant essential oils of the family Lamiaceae. We have investigated the analgesic effect of carvacrol, the possible dependence of the effect in relation to animal sex, and the impact of carvacrol on motor coordination in rats. Hyperalgesia was induced by formalin (1.5%), which was administered SC in the upper lip of rat. Hyperalgesia and effects of carvacrol and indomethacin were measured by using the orofacial formalin test. The infl uence on motor coordination in animals treated with carvacrol was investigated by using the rota-rod test. Carvacrol administered PO in pre-treatment (45 min. prior to formalin) at a single dose of 50, 75 and 100 mg /kg BW, in the male, 50 and 100 mg /kg BW, in female rats caused a dose-dependent antinociceptive effect. This effect of carvacrol was signifi cantly higher (P<0.01, P<0.001) in male rats. Compared with indomethacin administered during pre-treatment (2 mg/kg, PO), carvacrol (100 mg/kg) exhibits signifi cantly higher (P <0.05 and P <0.001) antinociceptive effect on formalininduced hyperalgesia in male rats. In the rota-rod test carvacrol did not disturb the motor coordination in male rats, nor the dose of carvacrol with clear antinociceptive properties exhibited depressive effect on the CNS of treated rats. Keeping in mind that the monoterpene carvacrol is of plant origin, with potentially less side effects and without residues, it is realistic to expect the possibility of its therapeutic use in the treatment of infl ammatory pain in animals.
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INTRODUCTION
Carvacrol (5-isopropyl-2methylphenol) is the monoterpene phenol. Together with other monoterpenes (thymol, p-cymene, limonene, α-terpinene), carvacrol is present in the essential oils of plants from the Lamiaceae family (1). The genus Thymus contains about 350 species, of which the most commonly are Thymus serpyllum and Thymus vulgaris, Oregano (Origanum vulgare) and Winter Savory (Satureja Montana). All of these species contain a high concentration of monoterpenes, and are used in the traditional medicine of many different cultures for the treatment of diseases of the respiratory and digestive tract (2) . So far, research into the pharmacological properties of carvacrol showed that it possesses antimicrobial [1, 2] , antiparasitic [3, 7] , anti-infl ammatory [5] , cytostatic [6] , analgesic [4] and antispasmodic effects [8] . Also, it was shown that carvacrol acts as an antioxidant, hypoglycemic and cholesterol lowering agent [8, 9] .
In addition to the well proven anti-infl ammatory effects of carvacrol [10] , recently, the researchers have become increasingly interested in the study of analgesic action of this monoterpene. It has been shown that carvacrol administered orally in mice reduces formalin-induced nociception, mechanical hyperalgesia and infl ammation in damaged tissues [11] . Also, Guimaraes et al [12] demonstrated that carvacrol administered orally in mice exhibits signifi cant antinociceptive and anti-edematous activity on hyperalgesia and edema caused by carrageenan and tumor necrosis factor-alpha (TNF-α). However, carvacrol exhibits no effect on the hyperalgesia induced by prostaglandin E2 (PGE2) and dopamine. Proven antinociceptive activity have other monoterpenes, such as p-cymene and geranyl acetate [13] . Similarly, the essential oil of rosemary (Rosmarinus offi cinalis) comprising predominant 1.8-cineole, camphor and α-pinene [14] , exhibits a signifi cant antinociceptive effect in the acetic acid-induced writhing test in mice [15] .
The above studies clearly indicate the analgesic potential of carvacrol, and the fact that this monoterpene is of vegetable origin, its possible application in the pharmacotherapy of pain (fewer side effects). These data directed our study on the investigations of carvacrol analgesic properties in the model of infl ammatory pain.
The aim of this study was to investigate the antinociceptive effect of carvacrol in the model of infl ammatory pain and the impact of carvacrol on motor coordination in male and female rats.
MATERIALS AND METHODS

Ethical approval
All experimental procedures where performed with the permission of the Ministry of Agriculture, Forestry and Water Management of the Republic of Serbia-Veterinary Directorate (permit N°323-07-05566/20I5 -05/1).
Animals
Adult male Wistar rats (180-220g) used in the present study were taken from the Military Academy Breeding Farm, Belgrade, Serbia. The animals were housed in groups of four in home cages (42.5 × 27 × 19 cm) under standard conditions: temperature of 21±1 o C, relative humidity of 55-60% and 12/12h light/dark cycle. Food and water were provided ad libitum, except during the experimental procedure.
The animals were habituated individually in a Plexiglass chamber for 30 min before testing. All behavioural testing was done between 9:00 A.M. and 2:00 P.M.
For each tested dose of the test substances (carvacrol, indomethacin), as well as for the controls (absolute control=purifi ed water; vehicle-control=ethanol-aqueous solvent), were formed groups of 6 rats each.
Drugs and administration
Substances used in this study were: formalin (Zorka Pharma), carvacrol (SigmaAldrich), indomethacin (Sigma-Aldrich), absolute ethanol (Zorka Pharma), saline (Hemofarm), and purifi ed water (Aq. purif.). Concentrated formalin (35%) was diluted with saline, carvacrol with ethanol-aqueous solvent, and indomethacin was dissolved in the ethanol-aqueous solvent. Absolute control group of rats was treated orally (PO) with purifi ed water, while vehicle-control group was treated orally with ethanol-aqueous solvent. Other groups of rats were treated orally with carvacrol or indomethacin. Oral administration was performed using a gastric tube. Volume of carvacrol, indomethacin or vehicle did not exceed 0.1 ml/100 g body weight (BW).
Experimental methods
The orofacial formalin test
To determine the severity of infl ammatory pain (nociception), the orofacial formalin test was applied. The test is intended for assessing the intensity of nociception caused by subcutaneous (SC) injection of formalin (1.5%, 0.1 ml) in rats upper lip (about 3-5 mm lateral to the nasal openings). Formalin injection causes infl ammation and nociception which expresses the energy, fast rubbing perinasal region (upper lip, nose) ipsilateral front or rear paw, or both front paws. This response is biphasic. First, acute (nociceptive) phase begins immediately after application of a formalin solution and lasts for 3-5 minutes. Then follows the grace period (10-15 min). Second, tonic (infl ammatory) phase begins after the end of the grace period and lasts 20-40 minutes. The parameter that was measured was the time expressed in seconds (s) that a rat spends in nociceptive behaviour. In experiments the recording time is generally divided into 15 blocks of 3 min for a time course analysis [16] .
Rota-rod motor coordination test
For testing the possible impact of carvacrol on the motor coordination in the rats "Rota-rod" test was used. This test measured the ability of the rat to preserve balance holding itself on the rotating rod.
Motor performance was assessed by means of an automated Rota-rod and software and database developed by El Unit, Belgrade, Serbia. Before the beginning of the sessions, all animals were allowed to habituate with the apparatus during 1 min with no rotation and for 5 min with a low speed rotation (4 rpm). Then, the speed of the rotation increased from 4 to 15 rpm (during 5 min). The test was performed on welltrained two groups per 6 rats. One is the vehicle-control group and the second is the carvacrol treated group. The effect of the maximal dose of carvacrol (100 mg/kg) on the integrity of motor coordination was assessed based on the ability of rats to stay on a rotated rod for 5 min without falling for 0, 45, 90 and 180 min after drug administration. The rats were trained during 5 days before the application of carvacrol to obtain an optimal level of performances, and the performances of the last day were used as the reference value [17] .
Righting refl ex and tail pinch test were used to determine possible clinical visible general depressive effects of the applied carvacrol on the rats CNS. A positive tail-pinch response was considered to be a movement of the body on a fl at surface in response to a pinch of the tail by forceps. The righting refl ex was considered normal when the rat could right itself from a prone position. All tests were conducted immediately after the application of drug and before placing it on the rotating rod [17] .
Statistical analysis
The data were statistically analysed by linear regression, One-Way Analysis of Variance (ANOVA) and the post hoc Tukey`s HSD test for multiple comparisons. A level of P<0.05 was considered statistically signifi cant.
RESULTS
Examination of antinociceptive effect of carvacrol in male and female rats
Carvacrol administered PO in the increasing doses of 50, 75 and 100 mg/kg, 45 minutes before formalin injection (1.5%; 0.1ml), produced a signifi cant dosedependent antinociceptive effect (p<0.05, p<0.01, p<0.001) in male rats. A signifi cant antinociceptive effect of carvacrol was observed with the two higher tested doses (75 and 100 mg/kg), and at both phases the formalin-induced nociception. Carvacrol administered in the lowest dose of 50 mg/kg, achieved an antinociceptive effect in the fi rst phase of the formalin-induced nociception, in the time interval of 3-6 minutes, as well as in the fi nal part of the second tonic phase of the formalin-induced nociception. Those effects of carvacrol exhibited minimal statistical signifi cance (Fig.1) . Dose-dependence of the antinociceptive effect of carvacrol was confi rmed by the constructed regression lines for both phases of nociception induced by formalin (Fig.2) .
Carvacrol administered PO in the higher dose (100 mg/kg) to female rats 45 minutes prior application of formalin (1.5%, 0.1ml, SC) caused a signifi cant reduction (p<0.05, p<0.01, p<0.001) in the formalin-induced nociception (both phases). On the other hand, the lower dose (50 mg/kg) of carvacrol had an insignifi cant effect on the nociception induced by formalin (Fig. 3) .
The ethanol-aqueous solvent (0.1 ml, PO) used for the dilution of carvacrol, did not affect the nociception caused by formalin in male and female rats (Fig.4A, B) . Antinociceptive effect of carvacrol (50, 75, 100 mg/kg) on the formalin-induced nociception in male rats. Carvacrol was administered PO, 45 min before formalin (1.5%, 0.1 ml, SC). The symbols denote mean ± SEM of 6 rats per group. * P<0.05, ** P<0.01 and ***P<0.01 vs. vehicle-control-M, one-way ANOVA followed by post hoc Tukey`s HSD test. Figure 2 . The regression lines of the antinociceptive effect of carvacrol (50, 75, 100 mg/kg, PO) at 6 min (fi rst phase) and 27 min (second phase) on the formalin-induced nociception in the orofacial formalin test in male rats (n=6). %AA-percent antinociceptive activity was calculated according to the following formula: %AA = (vehicle-control group average face rubbing (s) -test group average face rubbing (s)) / (vehicle-control group average face rubbing (s)) x 100 (18). Antinociceptive effect of carvacrol (50 and 100 mg/kg) on the formalin-induced nociception in female rats. Carvacrol was administered PO, 45 min before formalin (1.5%, 0.1 ml, SC). The symbols denote mean ± SEM of 6 rats per group. * P<0.05, ** P<0.01 and ***P<0.01 vs. vehicle-control-F, one-way ANOVA followed by post hoc Tukey`s HSD test.
Examination of differences in antinociceptive effect of carvacrol in relation to the sex of rats
In male and female rats carvacrol causes qualitatively the same antinociceptive effect on formalin-induced nociception of the perinasal region. By comparing the intensity of antinociceptive effects of carvacrol applied at a dose of 100 mg/kg in male and female rats, can be seen that this monoterpene achieved a signifi cantly greater antinociceptive effect (p<0.01, p<0.001) in male rats (Fig. 5) . Also, by comparing the intensity of formalin-induced nociception in the orofacial formalin test in relation to the sex of the animals, it is noticeable that the male rats are slightly less sensitive than females, but without statistical signifi cance (Fig. 6) . Comparison of the antinociceptive effect of carvacrol (100 mg/kg) on nociception induced by formalin in male and female rats. Carvacrol was administered PO, 45 min before formalin (1.5%, 0.1 ml, SC). The symbols denote mean ± SEM of 6 rats/group. ** P<0.01 and ***P<0.01 vs. vehicle-control-F, one-way ANOVA followed by post hoc Tukey`s HSD test. Figure 6 . Comparison of the nociception of perinasal region of the rats was induced by formalin (1.5%, 0.1ml, SC) in male and female rats. Vehicle-control-M and vehicle-control-F were treated PO with ethanol-aqueous solvent (0.1 ml), 45 min prior to formalin (n=6).
Comparative study of the antinociceptive effects of carvacrol and indomethacin in male rats
Indomethacin administered at a dose of 2 mg/kg, PO 45 minutes prior to the application of formalin (1.5%, 0.1ml), in the male rats causes a slight reduction of the nociception induced by formalin. Comparing the antinociceptive effect of carvacrol (100mg/ kg) and indomethacin (2 mg/kg) in male rats it is evident that carvacrol achieves a signifi cantly higher antinociceptive effect on the formalin-induced nociception, than analgoantipyretic indomethacin administered at the recommended dose (Fig.7) .
Effect of carvacrol on motor cordination in male rats
Male rats treated with ethanol-aqueous solvent (0,1ml/100g BW) (vehicle-control group, n=6) did not fall off the rotating rod for 0, 45, 90 and 180 min after vehicle administration. Also, the male rats treated with carvacrol at the maximal dose of 100 mg/kg did not show disturbances of motor coordination in any time point of measurement (Tab.1). All tested rats did not display visible signs of CNS depression, righting reflex was fully preserved and walking on a flat static surface (after tail pinch test) was normal. 
DISCUSSION
In the present study carried out on Wistar rats of both sexes, carvacrol administered orally in pre-treatment of formalin-induced hyperalgesia achieved a dose-dependent analgesic effect. The results of this experiment are matched with the results published by Santana et al. These authors have achieved an antinociceptive effect of carvacrolpropionate when this derivate of monoterpene administered to mice orally in the same dosage range (25, 50, 100 mg/kg) in the pre-treatment of hyperalgesia caused by formalin [11] . Also, Bonfi t et al showed that isoproxy-carvacrol administered intraperitoneally (10, 30 , 100 mg/kg) in the pre-treatment of formalin-induced hyperalgesia in mice and in the pre-treatment of carrageenan-induced hyperalgesia in rats (paw pressure tests), achieved a signifi cant antinociceptive effect only at the highest dose (100 mg/kg) [19] . Dose-dependent antinociceptive effect of carvacrol was confi rmed using this monoterpene in other analgesic tests, such as acetic acidinduced writhing test and "hot-plate" test in mice [4] .
In the next part of our investigation we were interested to examine whether a difference in the analgesic effect of carvacrol exists with respect to the sex in rats. Thus, we have shown that the analgesic activity of carvacrol (100 mg/kg) is affected by sex, but response to formalin is not signifi cantly infl uenced by sex. However, in comparison with females, slightly less sensitivity of males to the development of formalin hyperalgesia might be responsible, at least partially for their higher sensitivity to the effect of carvacrol administered in the highest dose of 100 mg/kg.
In the continuation of our research we compared the antinociceptive effect of carvacrol on formalin-induced nociception with the antinociceptive effect of standard analgoantipyretic indomethacin. Thus, carvacrol administered orally (100 mg /kg) in male rats exhibited a signifi cantly higher antinociceptive effect than indomethacin administered in the same way in the therapeutic dose (2 mg/kg). Analgesic activity of carvacrol (100 mg/kg) and indomethacin (5 mg/kg) in male mice was compared by Cavalcante Melo et al. These authors have observed the same coincidence of intensity in antinociceptive effects, which is in accordance with 2.5-fold higher dose of indomethacin administered in formalin test in mice [4] .
In the process of developing a new analgesic it is important to examine the impact of the potential drug on the coordination of movement, as well as the potential depressive effect on the CNS. In our study, carvacrol applied in the maximal tested dose of 100 mg /kg, did not disturb motor coordination in rats, and the applied dose did not produces visible clinical depression of the CNS. Similarly, the spontaneous locomotor activity of mice exposed to carvacrol (100 mg/ kg, IP) was not affected in the experiments performed by Guimarăes et al. [12] . If it is known that the oral LD 50 of carvacrol in the rat is 810 mg /kg BW, and that the major toxic effects of monoterpenes are related to the disorder of CNS (20) , it was expected that carvacrol in the highest tested dose (100 mg/kg) in our experiments is not able to alter the motor coordination in rats.
CONCLUSION
In the present study carried out on rats of both sexes is shown that: 1) carvacrol administered orally during pre-treatment on formalin-induced nociception achieves a dose-dependent antinociceptive effect in rats.
2) The analgesic activity of carvacrol in relation to the sex is the same in quality, but is different in quantity. This means that in male rats antinociceptive effect of carvacrol on formalin-induced nociception is signifi cantly higher than in females. 3) Comparing the antinociceptive effect of carvacrol and standard analgoantipyretic indomethacin on formalin-induced nociception in male rats is shown that carvacrol administered orally at the highest examined dose achieves a signifi cantly higher antinociceptive effect than indomethacin applied in the therapeutic dose. 4) Carvacrol does not affect the spontaneous locomotor activity and motor coordination in rats.
Bearing in mind the presented conclusions and the fact that carvacrol is a monoterpene of plant origin, with potentially less side effects and without residue, it is realistic to expect the possibility of its therapeutic use in the regulation of infl ammatory pain in animals.
